Hypoxia affects neprilysin expression through caspase activation and an APP intracellular domain-dependent mechanism

Frontiers in Neuroscience

Volumn 9, Issue NOV, 2015, Pages

  Kerridge, Caroline ^a,b   Kozlova, Daria I ^c   Nalivaeva, Natalia N ^a,c   Turner, Anthony J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

AICD; APP; Caspases; Hypoxia; Neprilysin

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; GLUCOSE TRANSPORTER 1; INTERLEUKIN 1BETA CONVERTING ENZYME; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA;

APOPTOSIS; ARTICLE; CASPASE 1 GENE; CASPASE 8 GENE; CASPASE 9 GENE; CELL HYPOXIA; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; NEP GENE; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 84949550990     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00426     Document Type: Article

References (64)

1. Ahmad, Y., Sharma, N. K., Ahmad, M. F., Sharma, M., Garg, I., and Bhargava, K. (2014). Proteomic identification of novel differentiation plasma protein markers in hypobaric hypoxia-induced rat model. PLoS ONE 9:e98027. doi: 10.1371/journal.pone.0098027.
2. Auerbach, I. D., and Vinters, H. V. (2006). Effects of anoxia and hypoxia on amyloid precursor protein processing in cerebral microvascular smooth muscle cells. J. Neuropathol. Exp. Neurol. 65, 610-620. doi: 10.1097/00005072-200606000-00009.
3. Banasiak, K. J., and Haddad, G. G. (1998). Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res. 797, 295-304.
4. Barnes, N. Y., Li, L., Yoshikawa, K., Schwartz, L. M., Oppenheim, R. W., and Milligan, C. E. (1998). Increased production of amyloid precursor protein provides a substrate for caspase-3 in dying motoneurons. J. Neurosci. 18, 5869-5880.
5. Bauer, C., Pardossi-Piquard, R., Dunys, J., Roy, M., and Checler, F. (2011). γ-Secretase-mediated regulation of neprilysin: influence of cell density and aging and modulation by imatinib. J. Alzheimers Dis. 27, 511-520. doi: 10.3233/JAD-2011-110746.
6. Beckett, C., Nalivaeva, N. N., Belyaev, N. D., and Turner, A. J. (2012). Nuclear signalling by membrane protein intracellular domains: the AICD enigma. Cell. Signal. 24, 402-409. doi: 10.1016/j.cellsig.2011.10.007.
7. Belyaev, N. D., Kellett, K. A., Beckett, C., Makova, N. Z., Revett, T. J., Nalivaeva, N. N., et al. (2010). The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a β-secretase-dependent pathway. J. Biol. Chem. 285, 41443-41454. doi: 10.1074/jbc. M110.141390.
8. Belyaev, N. D., Nalivaeva, N. N., Makova, N. Z., and Turner, A. J. (2009). Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep. 10, 94-100. doi: 10.1038/embor.2008.222.
9. Bertrand, E., Brouillet, E., Caillé, I., Bouillot, C., Cole, G. M., Prochiantz, A., et al. (2001). A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo. Mol. Cell. Neurosci. 18, 503-511. doi: 10.1006/mcne.2001.1030.
10. Caccamo, A., Oddo, S., Sugarman, M. C., Akbari, Y., and LaFerla, F. M. (2005). Age-and region-dependent alterations in Aβ-degrading enzymes: implications for Aβ-induced disorders. Neurobiol. Aging 26, 645-654. doi: 10.1016/j.neurobiolaging.2004.06.013.
11. Carpenter, T. C., and Stenmark, K. R. (2001). Hypoxia decreases lung neprilysin expression and increases pulmonary vascular leak. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L941-L948. Available online at: http://ajplung.physiology.org/content/281/4/L941.long.
12. D'Adamio, L., Shipp, M. A., Masteller, E. L., and Reinherz, E. L. (1989). Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5' untranslated regions. Proc. Natl. Acad. Sci. U.S.A. 86, 7103-7107.
13. Eisele, Y. S., Baumann, M., Klebl, B., Nordhammer, C., Jucker, M., and Kilger, E. (2007). Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-beta degrading enzyme neprilysin. Mol. Biol. Cell. 18, 3591-3600. doi: 10.1091/mbc. E07-01-0035.
14. Fang, H., Zhang, L. F., Meng, F. T., Du, X., and Zhou, J. N. (2010). Acute hypoxia promote the phosphorylation of tau via ERK pathway. Neurosci. Lett. 474, 173-177. doi: 10.1016/j.neulet.2010.03.037.
15. Finlay, D., Richardson, R. D., Landberg, L. K., Howes, A. L., and Vuori, K. (2010). Novel HTS strategy identifies TRAIL-sensitizing compounds acting specifically through the caspase-8 apoptotic axis. PLoS ONE 5:e13375. doi: 10.1371/journal.pone.0013375.
16. Fisk, L., Nalivaeva, N. N., Boyle, J. P., Peers, C. S., and Turner, A. J. (2007). Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem. Res. 32, 1741-1748. doi: 10.1007/s11064-007-9349-2.
17. Gervais, F. G., Xu, D., Robertson, G. S., Vaillancourt, J. P., Zhu, Y., Huang, J., et al. (1999). Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation. Cell 97, 395-406.
18. Hanson, L. R., Hafez, D., Svitak, A. L., Burns, R. B., Li, X., Frey, W. H., et al. (2011). Intranasal phosphoramidon increases beta-amyloid levels in wild-type and NEP/NEP2-deficient mice. J. Mol. Neurosci. 43, 424-427. doi: 10.1007/s12031-010-9460-8.
19. Hara, H., Oh-hashi, K., Yoneda, S., Shimazawa, M., Inatani, M., Tanihara, H., et al. (2006). Elevated neprilysin activity in vitreous of patients with proliferative diabetic retinopathy. Mol. Vis. 12, 977-982. Available online at: http://www.molvis.org/molvis/v12/a109/.
20. Hardy, J. (2009). The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J. Neurochem. 110, 1129-1134. doi: 10.1111/j.1471-4159.2009.06181.x.
21. Hardy, J. A., and Higgins, G. A. (1992). Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
22. Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., et al. (2000). Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150. doi: 10.1038/77399.
23. Jendroska, K., Poewe, W., Daniel, S. E., Pluess, J., Iwerssen-Schmidt, H., Paulsen, J., et al. (1995). Ischemic stress induces deposition of amyloid β immunoreactivity in human brain. Acta Neuropathol. 90, 461-466.
24. Kaufmann, M. R., Barth, S., Konietzko, U., Wu, B., Egger, S., Kunze, R., et al. (2013). Dysregulation of hypoxia-inducible factor by presenilin/γ-secretase loss-of-function mutations. J. Neurosci. 33, 1915-1926. doi: 10.1523/JNEUROSCI.3402-12.2013.
25. Kerridge, C., Belyaev, N. D., Nalivaeva, N. N., and Turner, A. J. (2014). The Aβ-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain. J. Neurochem. 130, 419-431. doi: 10.1111/jnc.12680.
26. Khurana, P., Ashraf, Q. M., Mishra, O. P., and Delivoria-Papadopoulos, M. (2002). Effect of hypoxia on caspase-3,-8, and-9 activity and expression in the cerebral cortex of newborn piglets. Neurochem. Res. 27, 931-938. doi: 10.1023/A:1020347732741.
27. Kim, T. W., Pettingell, W. H., Jung, Y. K., Kovacs, D. M., and Tanzi, R. E. (1997). Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277, 373-376.
28. Kochkina, E. G., Plesneva, S. A., Vasilev, D. S., Zhuravin, I. A., Turner, A. J., and Nalivaeva, N. N. (2015). Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues. Biogerontology 16, 473-484. doi: 10.1007/s10522-015-9569-9.
29. Kumar, G. K., Runold, M., Ghai, R. D., Cherniack, N. S., and Prabhakar, N. R. (1990). Occurrence of neutral endopeptidase activity in the cat carotid body and its significance in chemoreception. Brain Res. 517, 341-343.
30. Leissring, M. A., and Turner, A. J. (2013). Regulation of distinct pools of amyloid β-protein by multiple cellular proteases. Alzheimers Res. Ther. 5, 37. doi: 10.1186/alzrt194.
31. Li, C., Booze, R. M., and Hersh, L. B. (1995). Tissue-specific expression of rat neutral endopeptidase (neprilysin) mRNAs. J. Biol. Chem. 270, 5723-5728.
32. Li, L., Zhang, X., Yang, D., Luo, G., Chen, S., and Le, W. (2009). Hypoxia increases Aβ generation by altering β-and γ-cleavage of APP. Neurobiol. Aging 30, 1091-1098. doi: 10.1016/j.neurobiolaging.2007.10.011.
33. Li, Y., Zhou, C., Calvert, J. W., Colohan, A. R., and Zhang, J. H. (2005). Multiple effects of hyperbaric oxygen on the expression of HIF-1 alpha and apoptotic genes in a global ischemia-hypotension rat model. Exp. Neurol. 191, 198-210. doi: 10.1016/j.expneurol.2004.08.036.
34. Marr, R. A., and Spencer, B. J. (2010). NEP-like endopeptidases and Alzheimer's disease. Curr. Alzheimer Res. 7, 223-229. doi: 10.2174/156720510791050849.
35. Mohajeri, M. H., Kuehnle, K., Li, H., Poirier, R., Tracy, J., and Nitsch, R. M. (2004). Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease. FEBS Lett. 562, 16-21. doi: 10.1016/S0014-5793(04)00169-3.
36. Mumford, R. A., Strauss, A. W., Powers, J. C., Pierzchala, P. A., Nishino, N., and Zimmerman, M. (1980). A zinc metalloendopeptidase associated with dog pancreatic membranes. J. Biol. Chem. 255, 2227-2230.
37. Nalivaeva, N. N., Beckett, C., Belyaev, N. D., and Turner, A. J. (2012a). Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? J. Neurochem. 120(Suppl. 1), 167-185. doi: 10.1111/j.1471-4159.2011.07510.x.
38. Nalivaeva, N. N., Belyaev, N. D., Kerridge, C., and Turner, A. J. (2014). Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease. Front. Aging Neurosci. 6:235. doi: 10.3389/fnagi.2014.00235.
39. Nalivaeva, N. N., Belyaev, N. D., Lewis, D. I., Pickles, A. R., Makova, N. Z., Bagrova, D. I., et al. (2012b). Effect of sodium valproate administration on brain neprilysin expression and memory in rats. J. Mol. Neurosci. 46, 569-577. doi: 10.1007/s12031-011-9644-x.
40. Nalivaeva, N. N., Fisk, L., Kochkina, E. G., Plesneva, S. A., Zhuravin, I. A., Babusikova, E., et al. (2004). Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes. Ann. N.Y. Acad. Sci. 1035, 21-33. doi: 10.1196/annals.1332.002.
41. O'Brien, J. T., and Markus, H. S. (2014). Vascular risk factors and Alzheimer's disease. BMC Med. 12:218. doi: 10.1186/s12916-014-0218-y.
42. Oh-hashi, K., Nagai, T., Tanaka, T., Yu, H., Hirata, Y., and Kiuchi, K. (2005). Determination of hypoxic effect on neprilysin activity in human neuroblastoma SH-SY5Y cells using a novel HPLC method. Biochem. Biophys. Res. Commun. 334, 380-385. doi: 10.1016/j.bbrc.2005.06.095.
43. Ouiddir, A., Planès, C., Fernandes, I., VanHesse, A., and Clerici, C. (1999). Hypoxia upregulates activity and expression of the glucose transporter GLUT1 in alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 21, 710-718.
44. Pacheco-Quinto, J., and Eckman, E. A. (2013). Endothelin-converting enzymes degrade intracellular β-amyloid produced within the endosomal/lysosomal pathway and autophagosomes. J. Biol. Chem. 288, 5606-5615. doi: 10.1074/jbc. M112.422964.
45. Pardossi-Piquard, R., and Checler, F. (2012). The physiology of the β-amyloid precursor protein intracellular domain AICD. J. Neurochem. 120, 109-124. doi: 10.1111/j.1471-4159.2011.07475.x.
46. Pardossi-Piquard, R., Petit, A., Kawarai, T., Sunyach, C., Alves da Costa, C., Vincent, B., et al. (2005). Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron 46, 541-554. doi: 10.1016/j.neuron.2005.04.008.
47. Pluta, R., Jablonski, M., Ulamek-Koziol, M., Kocki, J., Brzozowska, J., Januszewski, S., et al. (2013). Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes. Mol. Neurobiol. 48, 500-515. doi: 10.1007/s12035-013-8439-1.
48. Qiu, W. Q., and Folstein, M. F. (2006). Insulin, insulin-degrading enzyme and amyloid-βpeptide in Alzheimer's disease: review and hypothesis. Neurobiol. Aging 27, 190-198. doi: 10.1016/j.neurobiolaging.2005.01.004.
49. Rybnikova, E., Gluschenko, T., Galeeva, A., Tulkova, E., Nalivaeva, N. N., Makova, N. Z., et al. (2012). Differential expression of ADAM15 and ADAM17 metalloproteases in the rat brain after severe hypobaric hypoxia and hypoxic preconditioning. Neurosci. Res. 72, 364-373. doi: 10.1016/j.neures.2011.12.010.
50. Selkoe, D. J. (2012). Preventing Alzheimer's disease. Science 337, 1488-1492. doi: 10.1126/science.1228541.
51. Semenza, G. L. (2006). Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp. Physiol. 91, 803-806. doi: 10.1113/expphysiol.2006.033498.
52. Strober, W. (2001). Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol. Appendix 3:Appendix 3B. doi: 10.1002/0471142735.ima03bs21.
53. Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., et al. (2006). Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl. Acad. Sci. U.S.A. 103, 18727-18732. doi: 10.1073/pnas.0606298103.
54. Turner, A. J. (2003). Exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveries. Biochem. Soc. Trans. 31, 723-727. doi: 10.1042/bst0310723.
55. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., et al. (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539. doi: 10.1038/416535a.
56. Wang, R., Zhang, Y. W., Zhang, X., Liu, R., Zhang, X., Hong, S., et al. (2006). Transcriptional regulation of APH-1A and increased γ-secretase cleavage of APP and Notch by HIF-1 and hypoxia. FASEB J. 20, 1275-1277. doi: 10.1096/fj.06-5839fje.
57. Wang, Z., Yang, D., Zhang, X., Li, T., Li, J., Tang, Y., et al. (2011). Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons. PLoS ONE 6:e19229. doi: 10.1371/journal.pone.0019229.
58. Webster, N. J., Green, K. N., Settle, V. J., Peers, C., and Vaughan, P. F. (2004). Altered processing of the amyloid precursor protein and decreased expression of ADAM 10 by chronic hypoxia in SH-SY5Y: no role for the stress-activated JNK and p38 signalling pathways. Brain Res. Mol. Brain Res. 130, 161-169. doi: 10.1016/j.molbrainres.2004.06.042.
59. Weidemann, A., Paliga, K., Dürrwang, U., Reinhard, F. B., Schuckert, O., Evin, G., et al. (1999). Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J. Biol. Chem. 274, 5823-5829.
60. Wick, M. J., Buesing, E. J., Wehling, C. A., Loomis, Z. L., Cool, C. D., Zamora, M. R., et al. (2011). Decreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 183, 330-340. doi: 10.1164/rccm.201002-0154OC.
61. Zhang, J. Z., Behrooz, A., and Ismail-Beigi, F. (1999). Regulation of glucose transport by hypoxia. Am. J. Kidney Dis. 34, 189-202.
62. Zhang, X., and Le, W. (2010). Pathological role of hypoxia in Alzheimer's disease. Exp. Neurol. 223, 299-303. doi: 10.1016/j.expneurol.2009.07.033.
63. Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., Liao, F. F., et al. (2007). Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and β-amyloid generation. J. Biol. Chem. 282, 10873-10880. doi: 10.1074/jbc. M608856200.
64. Zuccato, C., Belyaev, N., Conforti, P., Ooi, L., Tartari, M., Papadimou, E., et al. (2007). Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J. Neurosci. 27, 6972-6983. doi: 10.1523/JNEUROSCI.4278-06.2007.